These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21872093)

  • 1. Care of chronic liver disease.
    Jiang D
    Prim Care; 2011 Sep; 38(3):483-98; viii-ix. PubMed ID: 21872093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatology].
    Mondada D; Pache I; Leopold K; Thorens J; Moradpour D; Gonvers JJ
    Rev Med Suisse; 2006 Jan; 2(49):218-20, 223-6, 228-30. PubMed ID: 16493965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Highlights in hepatology].
    Pache I; Moradpour D
    Rev Med Suisse; 2008 Jan; 4(141):214, 216, 218-20. PubMed ID: 18335886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic viral hepatitis.
    Dakhil N; Junaidi O; Befeler AS
    Mo Med; 2009; 106(5):361-5. PubMed ID: 19902718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the fibrotic potential of nonalcoholic fatty liver disease and chronic hepatitis C.
    Charlotte F; Le Naour G; Bernhardt C; Poynard T; Ratziu V;
    Hum Pathol; 2010 Aug; 41(8):1178-85. PubMed ID: 20413144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monitoring patients with chronic hepatitis during and after therapy].
    Colić-Cvrlje V; Mise S
    Acta Med Croatica; 2009 Dec; 63(5):377-83. PubMed ID: 20198895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economics of chronic hepatitis B and hepatitis C.
    Rajendra A; Wong JB
    J Hepatol; 2007 Oct; 47(4):608-17. PubMed ID: 17697724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies.
    Poynard T; Ngo Y; Munteanu M; Thabut D; Massard J; Moussalli J; Varaud A; Benhamou Y; Ratziu V
    Antivir Ther; 2010; 15(4):617-31. PubMed ID: 20587855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adiponectin and chronic viral hepatitis].
    Yin HZ; Cao ZC
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):955-7. PubMed ID: 20038346
    [No Abstract]   [Full Text] [Related]  

  • 11. [Management of chronic viral hepatitis].
    Pache I; Mondada D; Moradpour D; Fontana M
    Rev Med Suisse; 2007 Jan; 3(95):215, 217-8, 221-3. PubMed ID: 17357690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut-liver axis: a new point of attack to treat chronic liver damage?
    Loguercio C; De Simone T; Federico A; Terracciano F; Tuccillo C; Di Chicco M; Cartenì M
    Am J Gastroenterol; 2002 Aug; 97(8):2144-6. PubMed ID: 12190198
    [No Abstract]   [Full Text] [Related]  

  • 13. Intrahepatic expression of c-fos, c-myb and c-myc oncogenes: correlation with virus-induced chronic liver disease and response to interferon.
    Tappero G; Farina M; Negro F; Anfossi G; Mattiello L; Giuli PD; Colombatto P; Brunetto MR; Angeli A; Bonino F
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):148-54. PubMed ID: 9646196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B and end-stage liver disease.
    Weisberg IS; Brown RS; Sigal SH
    Clin Liver Dis; 2007 Nov; 11(4):893-916, ix. PubMed ID: 17981234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic viral hepatitis in patients with renal disease.
    Fabrizi F; Martin P; Bunnapradist S
    Gastroenterol Clin North Am; 2004 Sep; 33(3):655-70, xi. PubMed ID: 15324949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic viral hepatitis as a public health issue in the world.
    Lavanchy D
    Best Pract Res Clin Gastroenterol; 2008; 22(6):991-1008. PubMed ID: 19187863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
    de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
    Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and histologic surveillance of hepatitis C].
    Bralet MP; Zafrani ES
    Rev Prat; 2000 May; 50(10):1078-82. PubMed ID: 10905092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liver cirrhosis in adults: etiology and specific treatments].
    Fartoux L; Serfaty L
    Rev Prat; 2005 Sep; 55(14):1539-48. PubMed ID: 16255295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.